Sunday, November 19, 2017 12:49:20 PM
As you later suggest... money.
Yes the latest PR where they had to address Canadian regulator concerns, outlines how Austrianova received $2M for each intended use of CIAB. Gunzberg is a founder of Austrianova. Why wouldn't he want to associate with PMCB, and influence new amendments, funneling more money into Austrianova?
Lohr believes agreeing to become a consultant for staging trials will put some money into his pocket. One of the earliest mention of him in that role for PMCB was to stage Phase 2 trials in Australia. If one does a search of the Australian clinical trial database for pancreatic cancer, there has never been a trial staged involving CIAB, or Ifosfamide. This isn't some holy grail crusade by Lohr in "believes". Doesn't matter to Lohr, if imaginary Australian clinical trials never took place. Lohr is getting paid to act as a consultant.
Go to the JDRF site. Read the article on the startup funding. They have their own proprietary encapsulation, claiming superior immune protection. And they use stem cell derived Islets. Note it has backing from the likes of Novartis. Why doesn't it add up, that advances have been made in encapsulation in the last 20 yrs? Or that the emphasis has shifted to stem cells rather than a tissue culture cell line (Magellan)? Next step will be someone finding a way to coax an individual's stem cells into Islets, and avoid the immunity problem.
Kenny has been pumping CIAB+Metronomic Ifosfamide chemo for Pancreatic cancer. No other drug company in the world is interested in Metronomic chemo with an alkylating agent against Pancreatic cancer. The world has moved onto targeted antibody therapy, along with new drugs. In addition Kenny has told the SHs, the FDA is wanting pre-clinical data. As in animal testing of a stable cell line. Possibly years away from an IND.
Kenny has been pumping CIAB for diabetes. But as discussed above, once again it's antiquated. And nothing has happened since 2014.
Kenny's final fallback scam angle try is cannabinoids being used against cancer. Where he would replay the CIAB+Ifosfamide, swapping out the Ifosfamide for some cannibinoid derivative. That one will also go nowhere.
As long as PMCB can sell its stock to retail investors, Kenny gets his salary, and Gunzberg, Lohr, along with others gets their consulting fees. In the case of Gunzberg arranging $2M here and there to flow into Austrianova from PMCB is even better. That's the game.
The Jewel of the Mind is Colored with the Hue of what it Imagines
Recent PMCB News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 08/13/2024 08:37:40 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 07/29/2024 08:05:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:59:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:58:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:58:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:58:35 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 08:05:04 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 05/30/2024 08:05:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 08:40:20 PM
- PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease • Business Wire • 05/21/2024 01:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:38:38 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 02:56:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/15/2023 10:25:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 09:00:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:00:10 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 11/22/2023 09:00:15 PM
- PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc. • Business Wire • 11/15/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 10:25:09 PM
- PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology • Business Wire • 10/31/2023 01:15:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM